Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19
Joseph Magagnoli, Siddharth Narendran, Felipe Pereira, Tammy Cummings, James W. Hardin, S. Scott Sutton, Jayakrishna Ambati
doi: https://doi.org/10.1101/2020.04.16.20065920
Joseph Magagnoli
1Dorn Research Institute, Columbia VA Health Care System, Columbia, South Carolina, USA
2Department of Clinical Pharmacy & Outcomes Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA
M.S.Siddharth Narendran
4Center for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, Virginia, USA
5Department of Ophthalmology, University of Virginia School of Medicine, Charlottesville, Virginia, USA
M.D.Felipe Pereira
4Center for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, Virginia, USA
5Department of Ophthalmology, University of Virginia School of Medicine, Charlottesville, Virginia, USA
M.D.Tammy Cummings
1Dorn Research Institute, Columbia VA Health Care System, Columbia, South Carolina, USA
Ph.D.James W. Hardin
3Department of Epidemiology & Biostatistics, University of South Carolina, Columbia, South Carolina, USA
Ph.D.S. Scott Sutton
1Dorn Research Institute, Columbia VA Health Care System, Columbia, South Carolina, USA
2Department of Clinical Pharmacy & Outcomes Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA
Pharm.D.Jayakrishna Ambati
4Center for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, Virginia, USA
5Department of Ophthalmology, University of Virginia School of Medicine, Charlottesville, Virginia, USA
6Department of Pathology, University of Virginia School of Medicine, Charlottesville, Virginia, USA
7Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, Virginia, USA
M.D.Data Availability
Data were extracted from the Veterans Affairs Informatics and Computing Infrastructure (VINCI), and thus are not publicly available.
Posted April 23, 2020.
Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19
Joseph Magagnoli, Siddharth Narendran, Felipe Pereira, Tammy Cummings, James W. Hardin, S. Scott Sutton, Jayakrishna Ambati
medRxiv 2020.04.16.20065920; doi: https://doi.org/10.1101/2020.04.16.20065920
Subject Area
Subject Areas
- Addiction Medicine (372)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2755)
- Dermatology (235)
- Emergency Medicine (414)
- Epidemiology (12403)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4263)
- Geriatric Medicine (396)
- Health Economics (699)
- Health Informatics (2758)
- Health Policy (1020)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (454)
- Neurology (4043)
- Nursing (216)
- Nutrition (600)
- Oncology (2129)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (478)
- Pediatrics (1149)
- Primary Care Research (470)
- Public and Global Health (6653)
- Radiology and Imaging (1446)
- Respiratory Medicine (886)
- Rheumatology (421)
- Sports Medicine (353)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)